Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor α-chain predicts a poor prognosis
Authors:
Open Access
- 4 January 2007
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 21 (2) , 326-332
Abstract
We quantitatively assessed the expression of cytokine receptors (interleukin-2 receptor (IL-2R), IL-3R, IL-4R, IL-5R, IL-6R, IL-7R, granulocyte-macrophage colony-stimulating factor R (GM-CSFR), G-CSFR, c-fms, c-mpl, c-kit and FLT3) in cells from 211 adults with acute lymphoblastic leukemia (ALL) by flow cytometry and determined their prevalence and clinical significance. Although all cytokine receptors were expressed to various degrees, the levels of IL-3R α-chain (IL-3Rα), IL-2Rα, IL-2Rβ, IL-7Rα, common-Rγ(γc), c-mpl, c-kit and FLT3 exhibited a wide spectrum 2000 sites/cell. Among them, IL-3Rα, IL-2Rα and FLT3 were highly expressed in B-lineage ALL, whereas IL-7Rα, γc and c-kit predominated in T-lineage ALL. Higher levels of IL-3Rα, IL-2Rα, c-kit and FLT3 correlated with the expression of CD13/33. Increased IL-2Rα levels related to the presence of Philadelphia chromosome (Ph), leukocytosis and shorter event-free survival (EFS). C-kit preferred in male. Elevated FLT3 levels correlated with age 60 years. Multivariate analysis in B-lineage ALL revealed only IL-2Rα (P=0.028) and Ph (P=0.020) as independent factors for EFS. These findings suggest that several cytokine receptors associated with certain cellular and clinical features, but IL-2Rα solely had a prognostic value and should be considered as a major prognostic factor for adult ALL that is comparable with Ph.Keywords
This publication has 31 references indexed in Scilit:
- High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study GroupJournal of Clinical Oncology, 2006
- Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemiaCancer, 2005
- Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 TrialJournal of Clinical Oncology, 2004
- Elevated expression of IL-3Rα in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosisBlood, 2002
- Expression of c-kit protein in proliferative lesions of human breast: sexual difference and close association with phosphotyrosine statusJournal of Cancer Research and Clinical Oncology, 2002
- Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remissionBone Marrow Transplantation, 1998
- Expression of CD25 (interleukin-2 receptor α chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts: results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993Leukemia, 1997
- Levels of soluble interleukin-2 receptors are predictive of response in patients treated with interleukin-2 and lymphokine-activated killer cellsMedical Oncology, 1995
- Diagnostic and clinical importance of interleukin‐2 receptor alpha chain expression on non‐T‐cell acute leukaemia cellsBritish Journal of Haematology, 1992
- Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid originBritish Journal of Haematology, 1990